Submit a manuscript Sign up for article alerts Contact us Support

About Investigative Genetics

This page includes information about the aims and scope of Investigative Genetics, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.

Aims & scope

Investigative Genetics is a peer-reviewed, open access, online journal that publishes articles on the development and application of molecular genetics in a wide range of science disciplines with societal relevance. These include evolutionary, anthropological and historical studies, forensic issues and legal medicine, as well as epidemiology and biosafety.

Investigative Genetics aims to provide a venue for novel, cutting-edge research and technological developments that will, through the application of molecular genetics, answer questions of past and present life, enhance life quality, and provide a safer living environment.

Investigative Genetics is divided into 10 sections, covering divergent areas of applied molecular genetics:

• Anthropological genetics
• Human population genetics
• Ancient DNA
• Forensic genetics
• Human safety and microbial genetics
• Consumer genetics
• Genetic technology and methodology
• Statistical genetics
• Pharmacogenetics
• Genetic diagnostics and casework

In addition, articles addressing the important issues of statistics, validity, reliability, and ethics related to the use and understanding of genetics will be published.

Investigative Genetics is a journal that reflects the breadth of molecular genetic research, development and validation and its application to the greater understanding and safety of our society. The journal bridges the gap between different areas of science that similarly exploit molecular genetics, allowing findings and developments to be disseminated efficiently and effectively among disciplines. Suitable articles are hypothesis-driven and apply, if appropriate, statistical principles; purely descriptive studies are of limited interest.

Open access

All articles published by Investigative Genetics are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

Authors of articles published in Investigative Genetics are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.

For authors who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

Open access publishing is not without costs. Investigative Genetics therefore levies an article-processing charge of £1565/$2450/€1995 for each article accepted for publication. If the corresponding author's institution is a Member, the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.

Indexing services

All articles published in Investigative Genetics are included in:

  • CAS
  • Google Scholar
  • PubMed
  • PubMed Central
  • Scopus

The full text of all research articles is deposited in digital archives including e-Depot (The Netherlands).

The full text of all research articles published by BioMed Central is also available on SpringerLink.

BioMed Central is working closely with Thomson Reuters (ISI) to ensure that citation analysis of articles published in Investigative Genetics will be available.

Publication and peer review process

Criteria for publication

Investigative Genetics considers the following types of article:

Research: reports of data from original research.

Reviews: summaries of recent insights in specific research areas within the scope of the journal.

Short reports: brief reports of data from original research.

Methodology articles: presentations of a new experimental method, test or procedure.

Commentaries: short, narrowly focused articles of contemporary interest. These are usually commissioned by the journal.

Opinion: brief articles that express expert opinions and new views on major subjects within the scope of the journal.

Letters to the Editor: these can take three forms: a substantial re-analysis of a previously published article or a substantial response to such a re-analysis from the authors of the original publication; an article that may not cover 'standard research' but that may be relevant to readers; or a brief report of research findings adequate for the journal's scope and of particular interest to the community.

Book reviews: summaries of the strengths and weaknesses of a book. They evaluate the books overall usefulness to the intended audience.

Meeting reports: a short description of a conference that the author has attended, which focuses on the key developments presented and discussed at the meeting.

Peer-review policies

All manuscripts are reviewed by internationally recognized experts in the field, selected in part from our Editorial Board. First and final decisions are made by the Editors-in-Chief.

Edited by Bruce Budowle, Antti Sajantila and Manfred Kayser, Investigative Genetics is supported by an expert Editorial Board.

Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Investigative Genetics, a personalized section of the site.

Copyediting and proofs

Investigative Genetics will copyedit manuscripts before they are published.

Following the acceptance of an article, it is published in Investigative Genetics as a provisional PDF file with minimal delay (subject to formatting checks, copyediting and author verification). Fully formatted PDF and full-text (HTML) versions are made available shortly after that.


High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.


Investigative Genetics will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. For further information, please contact us.

Editorial policies

All manuscripts submitted to Investigative Genetics should adhere to BioMed Central's editorial policies.

Citing articles in Investigative Genetics

Articles in Investigative Genetics should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Invest Genet [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Invest Genet 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Why publish your article in Investigative Genetics?

High visibility

Investigative Genetics's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.

Speed of publication

Investigative Genetics offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF; the article will then be available through Investigative Genetics and BioMed Central.


Online publication in Investigative Genetics gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Investigative Genetics are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Investigative Genetics's pages and on the BioMed Central homepage.

In addition, articles published in Investigative Genetics may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Investigative Genetics. A list of articles recently press-released by journals published by BioMed Central is available here.

Authors of articles published in Investigative Genetics retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright policy and license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.